UK Markets open in 2 hrs 23 mins

GlaxoSmithKline plc (GS7.F)


Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
18.248-0.167 (-0.907%)
At close: 5:12PM CEST
Full screen
Previous close18.415
Open18.315
Bid18.250 x 110000
Ask18.291 x 110000
Day's range18.248 - 18.494
52-week range17.333 - 20.570
Volume4,816
Avg. volume5,048
Market cap90.53B
BetaN/A
PE ratio (TTM)41.10
EPS (TTM)N/A
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks2 days ago

    Top Stock Reports for Alphabet, GlaxoSmithKline & T-Mobile

    Top Stock Reports for Alphabet, GlaxoSmithKline & T-Mobile

  • Reuters3 days ago

    GlaxoSmithKline's new CEO prepares to trim drug pipeline

    GlaxoSmithKline's new chief executive, who has already made her mark with plans to divest some nutritional products, will turn next week to the main business of focusing the company's pipeline of new drugs. Despite her non-pharmaceutical background in consumer brands, Emma Walmsley sees improving drug research productivity as her top priority, and she wants Britain's biggest drugmaker to have fewer but potentially more lucrative new medicine launches in future.

  • Reuters - UK Focus3 days ago

    GlaxoSmithKline's new CEO prepares to trim drug pipeline

    GlaxoSmithKline (Other OTC: GLAXF - news) 's new chief executive, who has already made her mark with plans to divest some nutritional products, will turn next week to the main business of focusing the company's pipeline of new drugs. Despite her non-pharmaceutical background in consumer brands, Emma Walmsley sees improving drug research productivity as her top priority, and she wants Britain's biggest drugmaker to have fewer but potentially more lucrative new medicine launches in future.